Jump to content

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction (Q46937459)

From Wikidata
scientific article published on 9 February 2006
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
    scientific article published on 9 February 2006

      Statements

      Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction (English)

      Identifiers

       
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      edit